Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Glioblastoma cells can make androgens, which might help the tumor grow.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Herpes zoster infection can cause permanent hair color change in the affected area.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

No clear link between specific gene and hair loss in Mexican brothers.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Lowering testosterone speeds up wound healing in male mice.

A new gene, JMJD1C, may affect testosterone levels in men.

Testosterone may slow down wound healing and increase inflammation.

DHT stops hair regrowth in mice, similar to human hair loss.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.